Myoclonic dystonia 15

Myoclonic dystonia 15 (DYT15, also referred to as myoclonus-dystonia syndrome type 15 or alcohol-responsive myoclonic dystonia) is a rare movement disorder characterized by the combination of myoclonus (sudden, brief, involuntary muscle jerks) and dystonia (sustained or intermittent muscle contractions causing abnormal postures or repetitive movements). This form of myoclonic dystonia is genetically distinct from the more commonly described DYT11 form caused by SGCE mutations, and the precise genetic locus for DYT15 has been mapped to chromosome 18p11 in a single large family. The condition primarily affects the neurological system, with myoclonus typically involving the upper body, including the neck, trunk, and arms, while dystonia most commonly manifests as writer's cramp or cervical dystonia. Symptoms generally begin in childhood or adolescence and may show a notable response to alcohol ingestion, which temporarily alleviates the myoclonic jerks. Psychiatric comorbidities, including anxiety, depression, and obsessive-compulsive disorder, have been reported in some affected individuals, consistent with other forms of myoclonus-dystonia. The disease follows an autosomal dominant inheritance pattern with variable expressivity, meaning that affected family members may show different degrees of severity. Treatment is primarily symptomatic and may include medications such as benzodiazepines (e.g., clonazepam), anticholinergics, or sodium oxybate. Deep brain stimulation targeting the globus pallidus internus has been used in severe, medication-refractory cases of myoclonus-dystonia syndromes more broadly. There is currently no cure, and management focuses on improving quality of life and functional ability.

Common questions about Myoclonic dystonia 15